Literature DB >> 20938672

Ethical guidelines in psychiatric research.

Hanfried Helmchen1.   

Abstract

Capacity to consent is a basic prerequisite for participation of patients as probands in research. However, mental illness often impairs this competence. Therefore, in psychiatric research, the first obligation is to assess a mentally ill patient's competence to consent. This is not a simple task. Informed consent should be viewed not only as a legal must, but also as a chance to build up a trusting patient-psychiatrist relationship. This is called for by respect for the autonomy and dignity of the patient. Specifically, competence to consent is related to the specific intervention; the validity of a consent requires that the patient understands the intervention-related medical information, comprehends its significance and consequences, and can appreciate its meaning for himself. Research with patients who lack this competence to consent validly meets a major problem: an uncovered need for research in frequent major psychiatric disorders exists, but a substantial number of patients with these illnesses cannot consent validly. Several guidelines for dealing with this problem will be discussed. Mentally ill patients who are willing to participate in needed research are a rare resource. This must be protected by the virtue of the clinical researcher who has to take great pains over the strict adherence to ethical guidelines.

Entities:  

Mesh:

Year:  2010        PMID: 20938672     DOI: 10.1007/s00406-010-0132-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  11 in total

Review 1.  Ethical issues in the design and conduct of randomised controlled trials.

Authors:  S J Edwards; R J Lilford; D A Braunholtz; J C Jackson; J Hewison; J Thornton
Journal:  Health Technol Assess       Date:  1998-12       Impact factor: 4.014

2.  Placebo-controlled trials.

Authors:  B Djulbegovic
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

3.  A new brief instrument for assessing decisional capacity for clinical research.

Authors:  Dilip V Jeste; Barton W Palmer; Paul S Appelbaum; Shahrokh Golshan; Danielle Glorioso; Laura B Dunn; Kathleen Kim; Thomas Meeks; Helena C Kraemer
Journal:  Arch Gen Psychiatry       Date:  2007-08

4.  Agreement between instruments for rating treatment decisional capacity.

Authors:  Ronald J Gurrera; Michele J Karel; Armin R Azar; Jennifer Moye
Journal:  Am J Geriatr Psychiatry       Date:  2007-02       Impact factor: 4.105

5.  The obligation to participate in biomedical research.

Authors:  G Owen Schaefer; Ezekiel J Emanuel; Alan Wertheimer
Journal:  JAMA       Date:  2009-07-01       Impact factor: 56.272

6.  Teaching responsible conduct of research.

Authors: 
Journal:  Lancet       Date:  2009-11-07       Impact factor: 79.321

7.  The inherent paradox of clinical trials in psychiatry.

Authors:  H Helmchen; B Müller-Oerlinghausen
Journal:  J Med Ethics       Date:  1975-12       Impact factor: 2.903

8.  Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.

Authors:  Barton W Palmer; Laura B Dunn; Paul S Appelbaum; Sunder Mudaliar; Leon Thal; Robert Henry; Shahrokh Golshan; Dilip V Jeste
Journal:  Arch Gen Psychiatry       Date:  2005-07

9.  Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness.

Authors:  Jeffrey W Swanson; Marvin S Swartz; Eric B Elbogen; Richard A Van Dorn; Joelle Ferron; H Ryan Wagner; Barbara J McCauley; Mimi Kim
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

10.  Medical decision-making capacity in patients with mild cognitive impairment.

Authors:  O Okonkwo; H R Griffith; K Belue; S Lanza; E Y Zamrini; L E Harrell; J C Brockington; D Clark; R Raman; D C Marson
Journal:  Neurology       Date:  2007-10-09       Impact factor: 9.910

View more
  2 in total

1.  Critical trial-related criteria in acute schizophrenia studies.

Authors:  Michael Riedel; Stefan Leucht; Eckart Rüther; Max Schmauß; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-26       Impact factor: 5.270

2.  Ethical issues in naturalistic versus controlled trials.

Authors:  Hanfried Helmchen
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.